
1. Moving the Markets
U.S. stocks fell on Tuesday, following weak manufacturing data from China. Stocks reversed course and gave back all of the solid gains achieved on Monday.
The lack of economic growth, here in the U.S., which I have alluded to in the past, continues to put a damper on financial markets. U.S. GDP, for example, logged a weak 0.5% in the initial read for Q1. Also, talk of a U.S. economy in so-called stall speed, coupled with contracting corporate earnings and continued uncertainty over central bank policy moves around the world, has held U.S. stocks back recently.
In stock specific news, iPhone maker Apple (APPL) was hoping to break an eight session losing streak, its longest since 1998. Apple shares are down 11% so far in 2016 and have tumbled nearly 13% in its eight-session slide. In early trading, Apple shares jumped 1.9% to $95.41.
On the earnings front, drug-maker Pfizer (PFE) topped quarterly earnings forecasts by 12 cents. Its shares were up sharply, rallying 3.2%.


Morgan Stanley is predicting 3-4 percent earnings growth in 2016 and in 2017, said Adam Parker, chief US equity strategist and director of quantitative research at Morgan Stanley.
After enduring turmoil in China and growth worries in Europe, emerging markets managed to get on its feet lately, as evidenced by the performance of different EM indices. That didn’t go unnoticed by Ohio-based Victory Capital, which recently launched a strategic beta fund focused on emerging markets.